欧洲皮内注射市场预测至 2028 年 - COVID-19 影响和按方法（正常尺寸针、短针和无针）、应用（结核菌素皮肤测试、过敏测试、局部美学等）和最终用户进行的区域分析（医院、诊断实验室、学术机构和研究机构等）
No. of Pages: 138 | Report Code: TIPRE00027988 | Category: Life Sciences
No. of Pages: 138 | Report Code: TIPRE00027988 | Category: Life Sciences
传染病和非传染性疾病发病率的增加推动市场增长
过去几年中，多种传染性和非传染性疾病的发病率呈指数级增长，这主要是由于现代世界不健康的生活方式。吸烟、感染和遗传因素可引起严重的呼吸道并发症、心血管疾病、细菌和病毒感染等，这些疾病是给各国公共医疗系统带来巨大负担的疾病之一。根据世界卫生组织的数据，每年观察到约 1000 万例结核病病例，所有结核病病例均通过结核菌素皮试（涉及皮内注射）进行诊断。多项研究表明，皮内注射可以改善各种抗癌和免疫药物的吸收，并且还可以用于提供基因治疗。 Pharmajet 的 Tropis ID 是一种新型皮内注射装置，在针对多种疾病的多种药物输送方面取得了显着的效果。
市场概况
英国、德国、法国、意大利、西班牙和欧洲其他国家是欧洲皮内注射市场的主要贡献者。德国在该地区市场占据主导地位。德国的众多医疗企业生产高品质、高性价比的产品。德国是仅次于美国的第二大医疗器械市场。根据 IGES 集团公司 AIM 的数据，德国医疗器械市场价值为 282.5 亿美元（250 亿欧元）。此外，该国政府已强制公民购买医疗保险。在德国，约 7140 万人享受公共医疗保险 Gesetzliche Krankenversicherung (GKV)，约 880 万人通过国家援助享受私人健康保险 Private Krankenversicherung (PKV)。根据世界卫生组织的数据，2020年结核病病例的检出率为约87%。此外，德国的结核病发病率为每10万人口约5.5例，这表明皮内注射的需求不断增加。老年人口的不断增加和过敏反应患病率的上升也推动了德国皮内注射市场的发展。该国拥有 400 多家专门为老年人提供服务的医院。因此，该国对无针注射等先进医疗设备的需求很高。随着美容手术的高度接受，皮内注射在美容手术中的使用也在该国增加。德国抓住这些机会，在医疗保健研究和基础设施方面进行了大量投资。根据欧盟统计局的数据，2015 年德国的医疗保健支出为 3.949 亿美元。与此同时，多家领先公司正在德国投资医疗器械制造。
欧洲皮内注射剂市场收入及预测至 2028 年（百万美元）
欧洲皮内注射剂市场细分
欧洲皮内注射剂市场根据方法、应用、最终用户和国家进行细分。
根据方法，市场分为普通针、短针和无针。普通尺寸针头细分市场在 2021 年占据了最大的市场份额。普通尺寸针头细分市场进一步细分为皮内微注射、微针阵列和纹身设备。短针段分为皮内液体喷射注射器和弹道式皮内注射器。
从应用来看，欧洲皮内注射剂市场细分为结核菌素皮试、过敏测试、当地审美等等。结核菌素皮试细分市场在 2021 年占据最大的市场份额。
欧洲皮内注射市场按最终用户划分，分为医院、诊断实验室、学术和研究研究所等。 2021 年，医院细分市场占据最大的市场份额。
根据国家/地区，市场分为英国、德国、法国、意大利、西班牙和其他国家/地区欧洲。德国在 2021 年占据市场主导地位。
BD;西制药服务公司；泰尔茂公司；纳米通行证； PharmaJet；伊德瓦克斯；银星全球；交叉投射；康德乐健康公司；和 Hindustan Syringes and Medical Devices Ltd 是欧洲地区皮内注射市场的领先公司。
Strategic insights for Europe Intradermal Injections involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,029.42 Million |
| Market Size by 2028 | US$ 2,131.06 Million |
| Global CAGR (2021 - 2028) | 11.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 方法
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Intradermal Injections refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Intradermal Injections Market is valued at US$ 1,029.42 Million in 2021, it is projected to reach US$ 2,131.06 Million by 2028.
As per our report Europe Intradermal Injections Market, the market size is valued at US$ 1,029.42 Million in 2021, projecting it to reach US$ 2,131.06 Million by 2028. This translates to a CAGR of approximately 11.0% during the forecast period.
The Europe Intradermal Injections Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Intradermal Injections Market report:
The Europe Intradermal Injections Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Intradermal Injections Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Intradermal Injections Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Intradermal Injections Market
